Provectus Biopharmaceuticals, Inc. (PVCT)
Market Closed
11 Sep, 20:00
OTC PINK OTC PINK Primary 
XSTU $
0. 06
+0
+5.5556%
$
23.79M Market Cap
- P/E Ratio
- Div Yield
41,500 Volume
0 Eps
$ 0.05
Previous Close Investors:
Want to track PVCT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Provectus Biopharmaceuticals, Inc. (PVCT) Shareholder/Analyst Call Transcript
Provectus Biopharmaceuticals, Inc. (PVCT) Shareholder/Analyst Call Transcript
Seekingalpha | 2 months ago
Provectus Biopharmaceuticals, Inc. (PVCT) Q4 2024 Earnings Call Transcript
Provectus Biopharmaceuticals, Inc. (OTC:PVCT) Q4 2024 Results Conference Call November 14, 2024 2:00 PM ET Company Participants Alyssa Barry - Co-Founder & Principal of Investor Relations, Alliance Advisors IR Ed Pershing - Chairman Dominic Rodrigues - Board Vice Chairman Alyssa Barry Good afternoon, good morning, good evening, depending on where you are. Welcome to Provectus Biopharmaceuticals Fourth Quarter Investor Update.
Seekingalpha | 1 year ago
